Clinical Trials Network: Long Island Regional Node

临床试验网络:长岛区域节点

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Long Island Node of the CTN was established in 2000 out of the seeds of long-standing collaborations between the Principal Investigator and his colleagues with several community-based treatment programs in Manhattan, Queens and Long Island. Our goals are to contribute to the fundamental work of the CTN by collaborating in the conduct of rigorous multi-site clinical trials testing the effectiveness of new treatments for drug dependence and promoting the dissemination and adoption of treatments found to be effective, through a network of community-based treatment providers. Our vision includes promoting the culture of evidence- based practice based on principles of bi-directionality such that both researchers and community-based clinicians are considered equal collaborators in the clinical research enterprise. Over the initial funding period, members of the Long Island Node have: 1) Provided performance sites for 9 CTN clinical trials, and participated in two completed survey studies, 2) Led two CTN national clinical trials, now completed and in data analysis; 3) Participated and/or obtained funding for 14 ancillary or platform studies; 4) Assumed national leadership as Chair of the HIV Workgroup, the Common Assessment Battery Workgroup, the Training Subcommittee, the Data Management Subcommittee, the Dissemination Subcommittee, the Research Utilization Committee, the Task Force on Secondary Analysis, as well as memberships on the Operations Subcommittee, the Executive Committee, and numerous other committees, interest and work groups; 5) Co-Chaired the second annual Blending Conference (2002), authored or coauthored 26 papers and one book, and delivered over 60 symposia, presentations and trainings at professional meetings; and 6) Initiated and fostered training and dissemination efforts in Buprenorphine, Motivational Interviewing and Motivational Incentives. This application requests funding for 3 additional years to continue the ongoing activities begun during the initial funding period and to develop new research and dissemination initiatives both locally and nationally. We will complete participation of sites in 3 CTN trials currently active or in start-up (CTN-0028, CTN-0029, CTN-0030), continue publication of results and dissemination efforts for the two studies we have led (CTN- 0015, CTN-0019), contribute sites to new CTN trials, participate in protocol development teams for the new HIV screening protocol and other new protocols, and continue leadership, training, and dissemination efforts at the national and local levels. We will also continue to encourage and seek outside funding for studies conducted on the CTN platform.
描述(申请人提供):CTN的长岛节点成立于2000年,是首席调查员和他的同事与曼哈顿、皇后区和长岛的几个社区治疗计划长期合作的种子。我们的目标是通过合作进行严格的多点临床试验来测试药物依赖新疗法的有效性,并通过社区治疗提供者网络促进被发现有效的治疗方法的传播和采用,从而为CTN的基本工作做出贡献。我们的愿景包括促进以双向原则为基础的循证实践文化,使研究人员和基于社区的临床医生在临床研究企业中被视为平等的合作者。在最初的供资期间,长岛节点的成员:1)为9项CTN临床试验提供绩效场地,并参与了两项已完成的调查研究;2)领导了两项CTN全国临床试验,现已完成并参与了数据分析;3)参与和/或获得了14项辅助或平台研究的资金;4)担任艾滋病毒工作组、共同评估小组工作组、培训小组委员会、数据管理小组委员会、传播小组委员会、研究利用委员会、二次分析工作队的主席,以及业务小组委员会、执行委员会和许多其他委员会、兴趣和工作组的成员;5)共同主持了第二届年度混合会议(2002年),撰写或共同撰写了26篇论文和一本书,并在专业会议上举办了60多场研讨会、演讲和培训;6)发起并促进了丁丙诺啡、激励性访谈和激励激励方面的培训和传播工作。这项申请要求再提供3年的资金,以继续在最初供资期间开展的活动,并在地方和国家范围内开展新的研究和传播活动。我们将完成目前正在进行或正在启动的3项CTN试验(CTN-0028、CTN-0029、CTN-0030)的站点参与,继续发布我们领导的两项研究(CTN-0015、CTN-0019)的结果和传播努力,为新的CTN试验贡献站点,参加新的艾滋病毒筛查方案和其他新方案的方案制定小组,并继续在国家和地方各级开展领导、培训和传播工作。我们还将继续鼓励和寻求外部资金,用于在CTN平台上进行的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward V. Nunes其他文献

Dissociative identity disorder and substance abuse: the forgotten relationship.
分离性身份障碍和药物滥用:被遗忘的关系。
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    David McDowell;Frances R. Levin;Edward V. Nunes
  • 通讯作者:
    Edward V. Nunes
Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis.
寻求治疗的药物滥用者的愤怒和抑郁状态:检验精神药理学特异性假设。
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    E. Aharonovich;Hueco T. Nguyen;Edward V. Nunes
  • 通讯作者:
    Edward V. Nunes
The neuropsychological assessment battery (S-NAB) in cocaine-dependent patients
  • DOI:
    10.1016/j.drugalcdep.2014.02.030
  • 发表时间:
    2014-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Efrat Aharonovich;Edward V. Nunes;D. Cannizzaro;M. Stohl;Deborah S. Hasin
  • 通讯作者:
    Deborah S. Hasin
New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders
  • DOI:
    10.1007/s11920-016-0703-4
  • 发表时间:
    2016-05-25
  • 期刊:
  • 影响因子:
    6.700
  • 作者:
    Elias Dakwar;Edward V. Nunes
  • 通讯作者:
    Edward V. Nunes
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
快速开始注射纳曲酮治疗阿片类药物使用障碍
  • DOI:
    10.1001/jamanetworkopen.2024.9744
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Matisyahu Shulman;Miranda G Greiner;Hiwot M. Tafessu;Onumara Opara;Kaitlyn Ohrtman;Kenzie Potter;Kathryn Hefner;Eve Jelstrom;Richard N Rosenthal;K. Wenzel;Marc Fishman;John Rotrosen;Udi E. Ghitza;Edward V. Nunes;Adam Bisaga
  • 通讯作者:
    Adam Bisaga

Edward V. Nunes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward V. Nunes', 18)}}的其他基金

NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10647100
  • 财政年份:
    2022
  • 资助金额:
    $ 125万
  • 项目类别:
NIDA Clinical Trials Network: Greater New York Node
NIDA 临床试验网络:大纽约节点
  • 批准号:
    9814170
  • 财政年份:
    2018
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    7514307
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8235961
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8037045
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8437265
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    7686108
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
New Approaches to Cocaine Abuse Medications
可卡因滥用药物的新方法
  • 批准号:
    7628364
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
  • 批准号:
    8069902
  • 财政年份:
    2007
  • 资助金额:
    $ 125万
  • 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
  • 批准号:
    7180794
  • 财政年份:
    2007
  • 资助金额:
    $ 125万
  • 项目类别:

相似海外基金

Creating Culturally Relevant HIV/ AIDS Education, Prevention & Treatment for Canadian Inuit
开展与文化相关的艾滋病毒/艾滋病教育和预防
  • 批准号:
    241932
  • 财政年份:
    2011
  • 资助金额:
    $ 125万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了